187 related articles for article (PubMed ID: 6170971)
1. Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.
VandenBurg MJ; Sharman VL; Morton JJ; Williams GH; Marsh FP
Postgrad Med J; 1981 May; 57(667):283-8. PubMed ID: 6170971
[TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension.
Gavras H; Gavras I; Textor S; Volicer L; Brunner HR; Rucinska EJ
J Clin Endocrinol Metab; 1978 Feb; 46(2):220-6. PubMed ID: 220274
[No Abstract] [Full Text] [Related]
3. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.
Morton JJ; Casals-Stenzel J; Lever AF; Millar JA; Riegger AJ; Tree M
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615
[TBL] [Abstract][Full Text] [Related]
4. The effect of the converting enzyme inhibitor SQ 20.881 on kinins, renin-angiotensin-aldosterone and catecholamines in relation to blood pressure in hypertensive patients.
Hulthén L; Hökfelt B
Acta Med Scand; 1978; 204(6):497-502. PubMed ID: 735881
[TBL] [Abstract][Full Text] [Related]
5. Accentuated vascular and endocrine response to SQ 20881 in hypertension.
Williams GH; Hollenberg NK
N Engl J Med; 1977 Jul; 297(4):184-8. PubMed ID: 195203
[TBL] [Abstract][Full Text] [Related]
6. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
[TBL] [Abstract][Full Text] [Related]
7. Relationship between aldosterone and bradykinin.
Mersey JH; Williams GH; Hollenberg NK; Dluhy RG
Circ Res; 1977 May; 40(5 Suppl 1):I84-8. PubMed ID: 870233
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women.
Umeda M; Ichikawa S; Kanda T; Sumino H; Kobayashi I
Am J Hypertens; 2001 Mar; 14(3):206-11. PubMed ID: 11281230
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin inhibitors for hypertension.
Gavras H; Gavras I; Brunner HR
Compr Ther; 1980 May; 6(5):14-8. PubMed ID: 6155240
[TBL] [Abstract][Full Text] [Related]
10. The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man.
Vinci JM; Horwitz D; Zusman RM; Pisano JJ; Catt KJ; Keiser HR
Hypertension; 1979; 1(4):416-26. PubMed ID: 232086
[No Abstract] [Full Text] [Related]
11. Prolonged treatment of high-renin hypertension with a converting enzyme inhibitor.
Vandenburg MJ; Sharman VL; Marsh FP; Rucinska EJ
Br Med J; 1978 Sep; 2(6141):866. PubMed ID: 709099
[No Abstract] [Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors.
Dipalma JR
Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
[No Abstract] [Full Text] [Related]
13. Treatment of hypertension with angiotensin converting enzyme inhibitors.
Johnston CI; McGrath BP; Matthews PG; Jackson B
Clin Exp Pharmacol Physiol Suppl; 1982; 7():135-44. PubMed ID: 6183036
[No Abstract] [Full Text] [Related]
14. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
Cohn JN; Levine TB
Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition.
Atkinson AB; Brown JJ; Fraser R; Lever AF; Morton JJ; Riegger AJ; Robertson JI
Clin Exp Hypertens (1978); 1980; 2(3-4):499-524. PubMed ID: 6253241
[TBL] [Abstract][Full Text] [Related]
16. The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects.
Sancho J; Re R; Burton J; Barger AC; Haber E
Circulation; 1976 Mar; 53(3):400-5. PubMed ID: 174834
[TBL] [Abstract][Full Text] [Related]
17. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
18. The use of angiotensin-converting enzyme inhibitor in the diagnosis and treatment of hypertension.
Gavras H; Brunner HR; Laragh JH; Gavras I; Vukovich RA
Clin Sci Mol Med Suppl; 1975 Jun; 2():57s-60s. PubMed ID: 1077792
[TBL] [Abstract][Full Text] [Related]
19. Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension.
Taylor T; Moore TJ; Hollenberg NK; Williams GH
Hypertension; 1984; 6(1):92-9. PubMed ID: 6198274
[TBL] [Abstract][Full Text] [Related]
20. Renal effects of angiotensin converting enzyme inhibitors in hypertension.
Bauer JH; Reams GP
Am J Med; 1986 Oct; 81(4C):19-27. PubMed ID: 3022581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
